CD19/CD22 CAR-T as First-line Consolidation in Follicular Lymphoma
Clinical trial NCT07587840 · RECRUITING
Trial details
- NCT number
- NCT07587840
- Sponsor
- Liping Dou
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2027-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.